Article

ACR 2011: Challenges in Helping Patients Understand Risks and Benefits of Medications [VIDEO]

Conference|American College of Rheumatology

Marcus Owen, MD, practices rheumatology and internal medicine in Nashville, TN. In this video, Dr. Joseph Kim talks with Dr. Owen about what he hopes to take away from this year's ACR conference and also speaks about some of the biggest challenges he faces in helping patients understand risk and benefit of medications.

Marcus Owen, MD, practices rheumatology and internal medicine in Nashville, TN. In this video, Dr. Joseph Kim talks with Dr. Owen about what he hopes to take away from this year's ACR conference and also speaks about some of the biggest challenges he faces in helping patients understand risk and benefit of medications.

This activity is not sanctioned by, nor a part of, the American College of Rheumatology.

Related Videos
Ben Samelson-Jones,Ben Samelson-Jones, MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy MD, PhD: Validating Long-Term Safety of Hemophilia AAV Gene Therapy
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Jörn Schattenberg, MD | Credit: Novo Nordisk
Jörn Schattenberg, MD | Credit: Novo Nordisk
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Related Content
Pegcetacoplan Demonstrates Control in Both C5i-Experienced and Naïve PNH
December 11th 2024

Pegcetacoplan Demonstrates Control in Both C5i-Experienced and Naïve PNH

Victoria Johnson
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 27th 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Annette von Drygalski, MD, PharmD
December 9th 2024

Innovative Hemophilia Treatments Offer Hope Amid Lingering Clinical Challenges

Silas Inman
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Female patient discussing iron deficiency with care provider. | Credit: Shutterstock
December 8th 2024

Universal 25 µg/L Threshold for Iron Deficiency is Cost-Effective, Could Improve Management in US Women

Patrick Campbell
Rushad Patell, MD | Credit: BIDMC
December 8th 2024

GLP-1 Receptor Agonists Could Reduce Stroke Risk in Type 2 Diabetes

Patrick Campbell
© 2024 MJH Life Sciences

All rights reserved.